Kura Oncology's Unattributed VC Round

Kura Oncology raised a round of funding on March 12, 2015.

Kura Oncology is a clinical-stage biopharmaceutical company, creating personalized therapeutics for patients with cancer. The company's pipeline consists of four potent and selective small molecule dr…

Articles about Kura Oncology's Unattributed VC Round: